News
Leading pharmacy benefit managers are shifting away from lucrative rebates on biologic drugs and toward lower-cost biosimilar ...
The Arkansas House and Senate have approved a bill that would force pharmacy benefit managers from holding a pharmacy license ...
President Donald Trump last month fired FTC Commissioners Rebecca Kelly Slaughter and Alvaro Bedoya, the only two members ...
Nowadays, the Dallas-based billionaire spends the majority of his time taking on a $5 trillion opponent: the U.S. healthcare ...
CVS Health Inc (NYSE:CVS) on Tuesday named Brian Newman as executive vice president and chief financial officer designate, ...
Omada Health is joining forces with CVS Health's Caremark as part of the pharmacy benefit manager's weight management program ...
The U.S. Federal Trade Commission's lawsuit against pharmacy benefit managers (PBMs) over insulin pricing practices will ...
Co-production deals with adalimumab biosimilar manufacturers and PBMs have increased biosimilar adoption, but this consolidation of the drug supply chain could undercut competition.
Here are 10 recent healthcare industry lawsuits, settlements and legal developments that Becker's has reported since April 1: ...
Cigna’s Express Scripts has emerged as the largest pharmacy benefit manager in the U.S. by market share, overtaking long-time ...
The FTC chair had previously been recused from the lawsuit. But after consulting with ethics lawyers, Ferguson changed his ...
CVS Health is a BUY. Undervalued with growth potential, it outshines competitors despite sector challenges. See more on CVS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results